Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Adding 5-day decitabine to the conditioning regimen for haploidentical bone marrow transplantation in aplastic anaemia patients results in satisfactory clinical outcomes

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Data availability

Some or all data generated or used during the study are available in a repository or online in accordance with funder data retention policies (Provide full citations that include URLs or DOIs.)


  1. Chen J, Lee V, Luo CJ, Chiang AKS, Hongeng S, Tan PL, et al. Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group. Br J Haematol. 2013;162:383–91.

    Article  Google Scholar 

  2. Xu LP, Wu DP, Han MZ, Huang H, Liu QF, Liu DH, et al. A review of hematopoietic cell transplantation in China: data and trends during 2008–2016. Bone Marrow Transpl. 2017;52:1512–8.

    CAS  Article  Google Scholar 

  3. ElGohary G, El Fakih R, de Latour R, Risitano A, Marsh J, Schrezenmeier H, et al. Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT). Bone Marrow Transpl. 2020;55:1906–17.

    Article  Google Scholar 

  4. Choi J, Ritchey J, Prior JL, Holt M, Shannon WD, Deych E, et al. In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia. Blood. 2010;116:129–39.

    CAS  Article  Google Scholar 

  5. Benincasa G, Vasco M, Corrado A, Sansone A, Picascia A, Napoli C. Epigenetic‐based therapy in allogenic hematopoietic stem cell transplantation: novel opportunities for personalized treatment. Clin Transpl. 2021;35:14306.

    Article  Google Scholar 

  6. Thomas E, Nathan D, Santos G, Gordon-Smith E, Gale R, Rappeport J, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48:63–70.

    Article  Google Scholar 

  7. Greinix HT, Loddenkemper C, Pavletic SZ, Holler E, Socié G, Lawitschka A, et al. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice. Biol Blood Marrow Transplant. 2011;17:167–75.

    Article  Google Scholar 

  8. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21:389–401.

    Article  Google Scholar 

  9. Xu LP, Liu KY, Liu DH, Han W, Chen H, Chen YH, et al. A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia. Bone Marrow Transpl. 2012;47:1507–12.

    CAS  Article  Google Scholar 

  10. Wagner JL, Deeg HJ, Seidel K, Anasetti C, Doney K, Sanders J, et al. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience. Transplantation. 1996;61:54–61.

    CAS  Article  Google Scholar 

  11. Xu LP, Jin S, Wang SQ, Xia LH, Bai H, Gao SJ, et al. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol. 2017;10:25.

    Article  Google Scholar 

  12. Landman S, Cruijsen M, Urbano PCM, Huls G, van Erp PEJ, van Rijssen E, et al. DNA methyltransferase inhibition promotes Th1 polarization in human CD4 + CD25 high FOXP3 + regulatory T cells but does not affect their suppressive capacity. J Immunol Res. 2018;2018:1–13.

    Article  Google Scholar 

Download references


We thank the transplantation team of the Haematology Department of the First Affiliated Hospital of Harbin Medical University for their support. This study was supported by the National Natural Science Foundation of China (No. 81903966).

Author information

Authors and Affiliations



LQT was responsible for designing and writing the research scheme, screening potentially eligible patients, collecting and processing the data, performing statistical analysis of the data, and updating the list of references. YTW and RQL were responsible for the data collection, analysis, and completion of data statistics. JL and DG were responsible for the review, modification and improvement of the research scheme, analysis, and explanation of the data results. YQZ was responsible for analysing the statistical results, improving the experimental tables and figures, and giving feedback on the research report.

Corresponding authors

Correspondence to HuiBo Li or ShengJin Fan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tang, L., Wu, Y., Lei, R. et al. Adding 5-day decitabine to the conditioning regimen for haploidentical bone marrow transplantation in aplastic anaemia patients results in satisfactory clinical outcomes. Bone Marrow Transplant (2022).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI:


Quick links